| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03033869 |
| P698 | PubMed publication ID | 7889536 |
| P2093 | author name string | M De Lena | |
| A Paradiso | |||
| I Abbate | |||
| M Correale | |||
| T Tedone | |||
| F Schittulli | |||
| G Gargano | |||
| A M Catino | |||
| C D Dragone | |||
| M D Musci | |||
| P2860 | cites work | Expression of the pNR-2/pS2 protein in diverse human epithelial tumours | Q35993870 |
| The pS2 gene, mRNA, and protein: a potential marker for human breast cancer | Q37974748 | ||
| Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma | Q39761350 | ||
| Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line | Q44022263 | ||
| Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer | Q44390158 | ||
| Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy | Q44556147 | ||
| Improved sensitivity in the measurement of estrogen receptor in human breast cancer. | Q53734484 | ||
| Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. | Q54132129 | ||
| pS2 expression and response to hormonal therapy in patients with advanced breast cancer | Q68179309 | ||
| Characterization of laboratory working standard for quality control of immunometric and radiometric estrogen receptor assays. Clinical evaluation on breast cancer biopsies. Italian Committee for Hormone Receptor Assays Standardization | Q69128271 | ||
| Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity | Q70715599 | ||
| Hormone dependency of breast cancer | Q70902329 | ||
| The value of estrogen and progesterone receptors in the treatment of breast cancer | Q71432010 | ||
| Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7 | Q24635245 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa | Q28288778 | ||
| Primary structure of human protein pS2 | Q28291476 | ||
| The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein | Q33561391 | ||
| Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence | Q33837377 | ||
| Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. | Q34381218 | ||
| Prediction of relapse and survival in breast cancer patients by pS2 protein status | Q34643233 | ||
| Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line | Q35726298 | ||
| pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response | Q35984246 | ||
| P433 | issue | 1-3 | |
| P921 | main subject | monoclonal antibody | Q422248 |
| P304 | page(s) | 101-110 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Cell Biophysics | Q27710315 |
| P1476 | title | pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer | |
| P478 | volume | 22 |
Search more.